|
[1]
|
Pflugfelder, S.C., Solomon, A. and Stern, M.E. (2000) The Diagnosis and Management of Dry Eye—A Twen-ty-Five-Year Review. Cornea, 19, 644-649. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Smith, J.A., Albeitz, J., Begley, C., et al. (2007) The Epidemiology of Dry Eye Disease: Report of the Epidemiology Subcommittee of the International Dry Eye Workshop (2007). Ocular Surface, 5, 93-107. [Google Scholar] [CrossRef]
|
|
[3]
|
Yu, L.F., Yu, C.J., Dong, H., et al. (2021) Recent Develop-ments about the Pathogenesis of Dry Eye Disease: Based on Immune Inflammatory Mechanisms. Frontiers in Pharma-cology, 12, Article ID: 732887. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Hessen, M. and Akpek, E.K. (2014) Dry Eye: An Inflammatory Ocular Disease. Journal of Ophthalmic and Vision Research, 9, 240-250.
|
|
[5]
|
Gupta, A., Sadeghi, P.B. and Akpek, E.K. (2009) Occult Thyroid Eye Disease in Patients Presenting with Dry Eye Symptoms. American Journal of Ophthalmology, 147, 919-923. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Dastjerdi, M.H., Hamrah, P. and Dana, R. (2009) High-Frequency Topical Cyclosporine 0.05% in the Treatment of Severe Dry Eye Refractory to Twice-Daily Regimen. Cornea, 28, 1091-1096. [Google Scholar] [CrossRef]
|
|
[7]
|
Ryu, E.H., Kim, J.M., Laddha, P.M., et al. (2012) Therapeu-tic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis. Korean Journal of Ophthalmology, 26, 241-247. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Tam, P.M., Young, A.L., Cheng, L.L., et al. (2010) Topical 0.03% Tacrolimus Ointment in the Management of Ocular Surface Inflammation in Chronic GVHD. Bone Marrow Transplan-tation, 45, 957-958. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Tian, J., Chau, C., Hales, T.G., et al. (1999) GABA(A) Receptors Me-diate Inhibition of T Cell Responses. Journal of Neuroimmunology, 96, 21-28. [Google Scholar] [CrossRef]
|
|
[10]
|
Zhang, B.H., Vogelzang, A., Miyajima, M., et al. (2021) B Cell-Derived GABA Elicits IL-10(+) Macrophages to Limit Anti-Tumour Immunity. Nature, 599, 471. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Bhandage, A.K., Jin, Z., Korol, S.V., et al. (2018) GABA Reg-ulates Release of Inflammatory Cytokines from Peripheral Blood Mononuclear Cells and CD4(+) T Cells and Is Immu-nosuppressive in Type 1 Diabetes. Ebiomedicine, 30, 283-294. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Paul, A.M., Branton, W.G., Walsh, J.G., et al. (2014) GABA Transport and Neuroinflammation Are Coupled in Multiple Sclerosis: Regulation of the GABA Transporter-2 by Ganax-olone. Neuroscience, 273, 24-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Meng, J.X., Xin, X., Liu, Z., et al. (2016) Propofol Inhib-its T-Helper Cell Type-2 Differentiation by Inducing Apoptosis via Activating Gamma-Aminobutyric Acid Receptor. Journal of Surgical Research, 206, 442-450. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Tian, J., Dillion, B.J., Henley, J., et al. (2022) A GABA-Receptor Agonist Reduces Pneumonitis Severity, Viral Load, and Death Rate in SARS-CoV-2-Infected Mice. Frontiers in Immu-nology, 13, Article ID: 1007955. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Pflugfelder, S.C. and De Paiva, C.S. (2017) The Pathophysiol-ogy of Dry Eye Disease: What We Know and Future Directions for Research. Ophthalmology, 124, S4-s13. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Reins, R.Y., Lema, C., Courson, J., et al. (2018) MyD88 Defi-ciency Protects against Dry Eye-Induced Damage. Investigative Ophthalmology & Visual Science, 59, 2967-2976. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Schaumburg, C.S., Siemasko, K.F., De Paiva, C.S., et al. (2011) Ocular Surface APCs Are Necessary for Autoreactive T Cell-Mediated Experimental Autoimmune Lacrimal Keratoconjunctivitis. The Journal of Immunology, 187, 3653-3662. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Bandeen-Roche, K., Muñoz, B., Tielsch, J.M., et al. (1997) Self-Reported Assessment of Dry Eye in a Population-Based Setting. Investiga-tive Ophthalmology & Visual Science, 38, 2469-2475.
|
|
[19]
|
Moss, S.E., Klein, R. and Klein, B.E. (2000) Prevalence of and Risk Factors for Dry Eye Syndrome. Archives of Ophthalmology, 118, 1264-1268. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Solomon, A., Dursun, D., Liu, Z., et al. (2001) Pro- and An-ti-Inflammatory Forms of Interleukin-1 in the Tear Fluid and Conjunctiva of Patients with Dry-Eye Disease. Investigative Ophthalmology & Visual Science, 42, 2283-2292.
|
|
[21]
|
Pflugfelder, S.C., De Paiva, C.S., Tong, L., et al. (2005) Stress-Activated Protein Kinase Signaling Pathways in Dry Eye and Ocular Surface Disease. The Ocular Surface, 3, S154-S157. [Google Scholar] [CrossRef]
|
|
[22]
|
Xiang, Y.Y., Wang, S., Liu, M., et al. (2007) A GABAergic System in Airway Epithelium Is Essential for Mucus Overproduction in Asthma. Nature Medicine, 13, 862-867. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Rashid, S., Jin, Y., Ecoiffier, T., et al. (2008) Topical Omega-3 and Omega-6 Fatty Acids for Treatment of Dry Eye. Archives of ophthalmology, 126, 219-225. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Alam, S., Laughton, D.L., Walding, A., et al. (2006) Human Peripheral Blood Mononuclear Cells Express GABAA Receptor Subunits. Molecular Immunology, 43, 1432-1442. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Mendu, S.K., Bhandage, A., Jin, Z., et al. (2012) Different Subtypes of GABA-A Receptors Are Expressed in Human, Mouse and Rat T Lymphocytes. PLOS ONE, 7, e42959. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Prud’homme, G.J., Glinka, Y., Hasilo, C., et al. (2013) GABA Protects Human Islet Cells against the Deleterious Effects of Immunosuppressive Drugs and Exerts Immunoinhibitory Effects Alone. Transplantation, 96, 616-623. [Google Scholar] [CrossRef]
|